OTC & Nutraceuticals Hong Kong

Hong Kong NAD+ Supplements Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Hong Kong NAD+ Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Hong Kong · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.0 Mn Placeholder estimate
Estimate 2025 $1.1 Mn 0.2% of the global market
Projected 2034 $3.0 Mn 170.7% Adds $1.9 Mn over 9 forecast years
CAGR 2025–2034 11.7% Faster than 88% of 82 OTC & Nutraceuticals markets here
Key players 5 Companies profiled
  • Hong Kong is 0.18% of the global market.
  • In APAC, the largest is China at $53.2 Mn.
  • Fastest growing: India at 14.2% a year.
  • Hong Kong ranks 7th of 10 by size in APAC.

Market size projection

Hong Kong

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
NAD+ Supplements Market market size by year, Hong Kong
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.0 Mn — —
2025 (base) $1.1 Mn +$0.1 Mn —
2026 (forecast) $1.3 Mn +$0.1 Mn +11.7%
2027 (forecast) $1.4 Mn +$0.1 Mn +24.8%
2028 (forecast) $1.6 Mn +$0.2 Mn +39.4%
2029 (forecast) $1.7 Mn +$0.2 Mn +55.7%
2030 (forecast) $2.0 Mn +$0.2 Mn +73.9%
2031 (forecast) $2.2 Mn +$0.2 Mn +94.2%
2032 (forecast) $2.4 Mn +$0.3 Mn +117%
2033 (forecast) $2.7 Mn +$0.3 Mn +142.3%
2034 (forecast) $3.0 Mn +$0.3 Mn +170.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Hong Kong NAD+ Supplements Market Analysis at a glance
Market size, 2025$1.1 Mn placeholder estimate
Forecast, 2034$3.0 Mn placeholder estimate
Growth (CAGR), 2025–203411.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledNicotinamide Adenine Dinucleotide (NAD+) Supplements
SegmentsIngredient, form and distribution channel (see all)
Key playersChromaDex, Elysium Health, Thorne, Life Extension, Renue By Science (see all)
Regulator in Hong KongDrug Office and Centre for Food SafetySource: Drug Office, Department of Health. Checked 14 Nov 2026.Source: Centre for Food Safety. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Hong Kong NAD+ Supplements Market Analysis Executive Summary

NAD+ supplements, such as NMN and nicotinamide riboside, aim to raise levels of NAD+, a molecule linked to cell energy that falls with age.

Key segments of the NAD+ Supplements market include ingredient (Nicotinamide Riboside, NMN and NAD+ Direct) and form (Capsules, Powders and IV and Injections).

Bar chart: Hong Kong NAD+ Supplements market size, 2024–2034, placeholder estimates. $1.0 Mn in 2024, $1.1 Mn in 2025 and $3.0 Mn in 2034, 11.7% CAGR.
Hong Kong NAD+ Supplements market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Hong Kong NAD+ Supplements Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the NAD+ Supplements market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the NAD+ Supplements market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the NAD+ Supplements market.

Competitive Landscape for NAD+ Supplements Market in Hong Kong

The NAD+ Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for NAD+ Supplements Market in Hong Kong

NAD+ Supplements in Hong Kong: rules and health figures

Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health.⁠[1] Health supplements are generally regulated as food, overseen by the Centre for Food Safety; proprietary Chinese medicines must be registered with the Chinese Medicine Council.⁠[2] People aged 65 and over: 23.7% of people in 2025, the latest WHO figure for Hong Kong.⁠[3]

[1] Drug Office, Department of Health. Checked 14 Nov 2026.

[2] Centre for Food Safety. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern NAD+ Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Hong Kong.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in NAD+ Supplements right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

NAD+ Supplements in context

Hong Kong compared

  • People aged 65 and over: 23.7% of people (2025). World: 10.4% of people (2025). 2nd highest of the 16 countries we cover in APAC.[1]

[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the NAD+ Supplements market in Hong Kong?
Placeholder estimate: about $1.1 Mn in 2025, rising to about $3.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the NAD+ Supplements market in Hong Kong growing?
Placeholder estimate: about 11.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the NAD+ Supplements market report cover?
The report splits the market by ingredient (Nicotinamide Riboside, NMN, NAD+ Direct, Combination Formulas), form (Capsules, Powders, IV and Injections) and distribution channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retail, Specialty Stores).
Who are the key players in the NAD+ Supplements market?
Key players include ChromaDex, Elysium Health, Thorne, Life Extension and Renue By Science.
What is driving the NAD+ Supplements market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the NAD+ Supplements market. Older adults and their families are spending more on staying active and independent.
Who regulates NAD+ Supplements in Hong Kong?
Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health. Health supplements are generally regulated as food, overseen by the Centre for Food Safety; proprietary Chinese medicines must be registered with the Chinese Medicine Council. Source: Drug Office, Department of Health. Checked 14 Nov 2026. Source: Centre for Food Safety. Checked 14 Nov 2026.
What does WHO report for Hong Kong?
People aged 65 and over: 23.7% of people in 2025, the latest WHO figure. Source: WHO Global Health Observatory, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
How much research is published on NAD+ Supplements?
PubMed lists 1,091 papers on NAD+ Supplements added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related OTC & Nutraceuticals reports in Hong Kong

See all

Related on geriatric and nutrition

See the topic